Bone Marrow-derived CD8(+) T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

por Palen, Katie, Thakar, Monica, Johnson, Bryon D., Gershan, Jill A.
Publicado 2019

Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer

por Riese, Matthew J., Moon, Edmund K., Johnson, Bryon D., Albelda, Steven M.
Publicado 2016

Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma

por Gershan, Jill A., Barr, Kristen M., Weber, James J., Jing, Weiqing, Johnson, Bryon D.
Publicado 2015

E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells

por Palen, Katie, Weber, James, Dwinell, Michael B., Johnson, Bryon D., Ramchandran, Ramani, Gershan, Jill A.
Publicado 2016

PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

por Zurko, Joanna, Chaney, Katherine, Astle, John M., Johnson, Bryon D., Hari, Parameswaran, Shah, Nirav N.
Publicado 2021

Immune response modulation by curcumin in a latex allergy model

por Kurup, Viswanath P, Barrios, Christy S, Raju, Raghavan, Johnson, Bryon D, Levy, Michael B, Fink, Jordan N
Publicado 2007

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen

por Zheng, Jin, Kohler, M Eric, Chen, Qingrong, Weber, James, Khan, Javed, Johnson, Bryon D, Orentas, Rimas J
Publicado 2007

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma

por Jing, Weiqing, Gershan, Jill A, Weber, James, Tlomak, Dominique, McOlash, Laura, Sabatos-Peyton, Catherine, Johnson, Bryon D
Publicado 2015

Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice

por Jing, Weiqing, Gershan, Jill A., Blitzer, Grace C., Palen, Katie, Weber, James, McOlash, Laura, Riese, Matthew, Johnson, Bryon D.
Publicado 2017

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models

por Jing, Weiqing, McAllister, Donna, Vonderhaar, Emily P., Palen, Katie, Riese, Matthew J., Gershan, Jill, Johnson, Bryon D., Dwinell, Michael B.
Publicado 2019

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone

por Huang, Mofei, Xiong, Donghai, Pan, Jing, Zhang, Qi, Wang, Yian, Myers, Charles R., Johnson, Bryon D., Hardy, Micael, Kalyanaraman, Balaraman, You, Ming
Publicado 2022

Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: A role for the immune system

por Lenarczyk, Marek, Laiakis, Evagelia C., Mattson, David L., Johnson, Bryon D., Kronenberg, Amy, North, Paula E., Komorowski, Richard, Mäder, Marylou, Baker, John E.
Publicado 2020

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

por Taylor, Mallory R., Hillard, Cecilia J., Drobyski, William R., Szabo, Aniko, Johnson, Bryon D., Zhu, Fenlu, Raison, Charles L., Cole, Steve W., Knight, Jennifer M.
Publicado 2022

Immediate transfection of patient-derived leukemia: a novel source for generating cell-based vaccines

por Gershan, Jill A, Johnson, Bryon D, Weber, James, Schauer, Dennis W, Natalia, Natalia, Behnke, Stephanie, Burns, Karen, Maloney, Kelly W, Warwick, Anne B, Orentas, Rimas J
Publicado 2005

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer

por Vonderhaar, Emily P., Barnekow, Nicholas S., McAllister, Donna, McOlash, Laura, Eid, Mahmoud Abu, Riese, Matthew J., Tarakanova, Vera L., Johnson, Bryon D., Dwinell, Michael B.
Publicado 2021

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

por AbuEid, Mahmoud, McAllister, Donna M., McOlash, Laura, Harwig, Megan Cleland, Cheng, Gang, Drouillard, Donovan, Boyle, Kathleen A., Hardy, Micael, Zielonka, Jacek, Johnson, Bryon D., Hill, R. Blake, Kalyanaraman, Balaraman, Dwinell, Michael B.
Publicado 2021

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

por Pan, Jing, Chen, Yao, Zhang, Qi, Khatun, Achia, Palen, Katie, Xin, Gang, Wang, Li, Yang, Chuanjia, Johnson, Bryon D., Myers, Charles R., Sei, Shizuko, Shoemaker, Robert H., Lubet, Ronald A., Wang, Yian, Cui, Weiguo, You, Ming
Publicado 2021

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

por Mohammed, Altaf, Dashwood, Roderick H., Dickinson, Sally, Disis, Mary L., Jaffee, Elizabeth M., Johnson, Bryon D., Khleif, Samir N., Pollak, Michael N., Schlom, Jeffrey, Shoemaker, Robert H., Stanton, Sasha E., Wondrak, Georg T., You, Ming, Zhu, Hao, Miller, Mark Steven
Publicado 2021

Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System

por Chu, Yaya, Lamb, Margaret, Maryamchik, Elena, Rigot, Olivia, Ayello, Janet, Harrison, Lauren, Mintzer, Elizabeth, Shaw, Rosemarie, Behbehani, Gregory, Mardis, Elaine, Miller, Katherine, Rao Venkata, Lakshmi Prakruthi, Chang, Hsiaochi, Lee, Dean A., Rosenthal, Elana Y., Kadauke, Stephan, Bunin, Nancy J., Talano, Julie, Johnson, Bryon D, Wang, Yongping, Cairo, Mitchell S.
Publicado 2023

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

por Miller, Mark Steven, Allen, Peter J., Brown, Powel H., Chan, Andrew T., Clapper, Margie L., Dashwood, Roderick H., Demehri, Shadmehr, Disis, Mary L., DuBois, Raymond N., Glynn, Robert J., Kensler, Thomas W., Khan, Seema A., Johnson, Bryon D., Liby, Karen T., Lipkin, Steven M., Mallery, Susan R., Meuillet, Emmanuelle J., Roden, Richard B.S., Schoen, Robert E., Sharp, Zelton D., Shirwan, Haval, Siegfried, Jill M., Rao, Chinthalapally V., You, Ming, Vilar, Eduardo, Szabo, Eva, Mohammed, Altaf
Publicado 2021